Evaluation of effects of Ra-223 chloride therapy for bone metastasis of prostate cancer by quantitative bone SPECT/CT
Latest Information Update: 14 Jul 2021
At a glance
- Drugs Radium 223 chloride (Primary)
- Indications Bone metastases; Prostate cancer
- Focus Diagnostic use; Therapeutic Use
- 10 Jul 2021 Status changed from active, no longer recruiting to completed.
- 01 Apr 2019 Status changed from recruiting to active, no longer recruiting.
- 30 Sep 2016 New trial record